J&J | JNJ
Stock Price
165.67
Daily Change
0.55 0.33%
Monthly
8.22%
Yearly
4.28%
Q1 Forecast
163.91



Peers Price Chg Day Year Date
AbbVie 210.70 -0.85 -0.40% 16.69% Mar/06
Abbott 134.91 -2.71 -1.97% 11.57% Mar/06
Amgen 318.03 1.17 0.37% 16.55% Mar/06
AstraZeneca 11,979.00 -49.00 -0.41% 17.49% Mar/07
Baxter International 35.45 0.24 0.67% -17.55% Mar/06
Bayer 23.05 -1.81 -7.28% -12.29% Mar/07
Becton, Dickinson and Co. 225.21 1.03 0.46% -5.22% Mar/06
Biogen 147.32 3.43 2.38% -32.84% Mar/06
Bristol-Myers Squibb 60.12 0.27 0.45% 12.84% Mar/06
Boston Scientific 100.69 -4.10 -3.91% 49.35% Mar/06
CONMED 59.14 1.54 2.67% -30.42% Mar/06
Cooper Companies 90.98 -0.37 -0.41% -10.68% Mar/06
Dexcom 79.50 -2.50 -3.04% -40.33% Mar/06
Edwards Lifesciences 71.79 -1.16 -1.58% -18.73% Mar/06
Gilead Sciences 116.03 0.57 0.49% 57.52% Mar/06
Globus Medical 76.31 -2.51 -3.18% 40.33% Mar/06
GlaxoSmithKline 1,503.50 3.00 0.20% -10.13% Mar/07
Hologic 62.50 0.42 0.68% -18.11% Mar/06
Integra LifeSciences 22.03 0.16 0.73% -38.98% Mar/06
Indivior 762.00 7.00 0.93% -55.65% Mar/06
Intuitive Surgical 537.99 -29.84 -5.26% 37.00% Mar/06
J&J 165.67 0.55 0.33% 4.28% Mar/06
Eli Lilly 912.97 -16.94 -1.82% 17.02% Mar/06
Medtronic 93.22 -0.93 -0.99% 9.48% Mar/06
Merit Medical Systems 101.73 -3.12 -2.98% 34.97% Mar/06
Merck 93.93 0.72 0.77% -24.24% Mar/06
Novartis 100.02 0.55 0.55% 13.52% Mar/07
Pfizer 26.20 0.27 1.04% -2.20% Mar/06
Insulet 259.67 -11.14 -4.11% 47.97% Mar/06
Regeneron Pharmaceuticals 698.46 11.88 1.73% -28.24% Mar/06
Roche Holding 301.85 -0.85 -0.28% 26.72% Mar/07
Sanofi 108.98 -0.64 -0.58% 24.28% Mar/07
Stryker 381.93 -14.04 -3.55% 6.80% Mar/06
Teva Pharmaceutical Industries 5,610.00 -206.00 -3.54% 18.06% Mar/06
Tandem Diabetes Care 18.72 -0.39 -2.04% -36.91% Mar/06
Vertex Pharmaceuticals 485.83 -5.73 -1.17% 18.34% Mar/06
Zimmer Biomet Holdings 104.75 0.04 0.04% -16.75% Mar/06
Zoetis 167.27 0.28 0.17% -7.85% Mar/06

Indexes Price Day Year Date
US500 5761 -104.11 -1.78% 12.45% Mar/07
US30 42674 -427.52 -0.99% 10.20% Mar/07

Johnson & Johnson traded at $165.67 this Thursday March 6th, increasing $0.55 or 0.33 percent since the previous trading session. Looking back, over the last four weeks, J&J gained 8.22 percent. Over the last 12 months, its price rose by 4.28 percent. Looking ahead, we forecast Johnson & Johnson to be priced at 163.91 by the end of this quarter and at 160.44 in one year, according to Trading Economics global macro models projections and analysts expectations.

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism and pulmonary hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopedic, surgery, and vision fields.